Abstract
Several studies have shown that depression is a risk factor for the development of Alzheimer’s disease. Further, depressive symptoms can increase symptom severity (e.g., memory decline and executive dysfunction) and reduce the quality of life in patients with Alzheimer’s disease. Accordingly, this chapter attempts to review existing literature on several existing behavioral and pharmacological treatments for depression in Alzheimer’s disease. Based on our review of the literature, we provide evidence that behavioral treatments are more effective than most pharmacological therapies at managing depression in Alzheimer’s disease. Future research should investigate the mechanism by which behavioral treatments can exert their therapeutic effect.
| Original language | English |
|---|---|
| Title of host publication | Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy |
| Publisher | Academic Press |
| Chapter | 9 |
| Pages | 177-189 |
| Number of pages | 13 |
| ISBN (Electronic) | 9780128213346 |
| DOIs | |
| Publication status | Published - 2021 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Treatment of depression in Alzheimer’s disease'. Together they form a unique fingerprint.Related Research Outputs
- 1 Citations
- 1 Book
-
Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy
Moustafa, A. A., 2021, Academic Press. 238 p.Research output: Book/Report › Book › Research › peer-review
5 Link opens in a new tab Citations (Scopus)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver